FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156137002> ?p ?o ?g. }

• W3156137002 abstract "While radiotherapy (RT) is fundamental for the treatment of brain tumors, irradiation of the brain frequently causes devastating effects on cognitive function and quality of life. DNA damage within neural stem cells (NSC) is a key factor in the pathogenesis of radiation-induced cognitive dysfunction. The ataxia telangiectasia mutated (ATM) kinase is a central protein in the DNA damage response and a critical determinant of tumor cell survival after radiation. ATM inhibition potently radiosensitizes preclinical models of GBM <i>in vitro</i> and <i>in vivo</i>. A novel, brain penetrant ATM inhibitor AZD1390, which is predicted to achieve brain tumor concentrations in the range of 1-5nM, is currently in early phase clinical evaluation in combination with RT. In marked contrast to observations in tumor models, genetic knockdown of ATM has radioprotective effects on NSC <i>in vitro</i>; the proposed mechanism is via suppression of p53 mediated apoptosis. The purpose of this study was to investigate the impact of AZD1390 on survival responses and mode of death in NSCs exposed to RT <i>in vitro</i> and <i>in vivo</i>. NSCs were derived from the telencephalon of E13 mouse embryos. Cells were treated with AZD1390 (0.1-10nM) 1 hour prior to ionizing radiation (IR; 0-5 Gy). Mode and timing of cell death was interrogated using IncuCyte live cell analysis to measure proliferation, cytotoxicity and apoptosis up to 72 hours post-IR. Cell viability and neurosphere formation assays were also used to measure radiation sensitivity <i>in vitro</i>. C57BL/6 mice received 20Gy hemibrain irradiation +/- 7-day treatment with AZD1390 (10mg/kg). Immunohistochemistry for Ki67 and Sox2 was used to assess effects on NSC in the subventricular zone (SVZ) 50 days post-irradiation. <i>In vitro</i> AZD1390 (1-10nM) inhibited ATM kinase function within 1 hour, evidenced by abrogation of KAP1 and p53 phosphorylation. NSCs primarily undergo apoptosis in response to IR. AZD1390 at 1 and 3nM significantly reduced apoptosis in irradiated NSCs (ratios of annexin V area under the curve 1.95 and 2 respectively); 10 nM had no effect on this parameter. Proliferation rates and cell viability after radiation were preserved at all drug concentrations. AZD1390 at 1nM did not modulate radiation effects on neurosphere formation whereas at 10nM a radiosensitizing effect was observed (ratio of SF[3Gy]=0.25). <i>In vivo</i>, IR decreased the number of Ki67 positive proliferating cells (92% reduction) and Sox2-positive cells (24% reduction) in the SVZ after 50 days; these effects were not exacerbated by addition of AZD1390. Acute effects (24 hours post-IR) are under investigation. We demonstrate <i>in vitro</i> that AZD1390 has radioprotective effects on NSCs at clinically achievable concentrations. <i>In vivo</i>, treatment with AZD1390 did not enhance the effects of radiation on NSCs in the SVZ. In the context of its profound radiosensitizing effects on GBM models, the absence of radiosensitization of NSCs both <i>in vitro</i> and <i>in vivo</i> strengthens the rationale for evaluating AZD1390 in combination with RT in GBM patients. <b>Citation Format:</b> Rodrigo Guttierez-Quintana, David J. Walker, Mark R. Jackson, Natividad Gomez-Roman, Sandeep Chahal, Stephen T. Durant, Anthony J. Chalmers. Radiotherapy in combination with the brain penetrant ATM inhibitor AZD1390 does not exacerbate radiation toxicity of neural stem cells <i>in vitro</i> or <i>in vivo</i> [abstract]. In: Proceedings of the AACR Virtual Special Conference on Radiation Science and Medicine; 2021 Mar 2-3. Philadelphia (PA): AACR; Clin Cancer Res 2021;27(8_Suppl):Abstract nr PO-017." @default.
• W3156137002 created "2021-04-26" @default.
• W3156137002 creator A5001108212 @default.
• W3156137002 creator A5030868726 @default.
• W3156137002 creator A5032660674 @default.
• W3156137002 creator A5050483295 @default.
• W3156137002 creator A5055892643 @default.
• W3156137002 creator A5070984695 @default.
• W3156137002 creator A5084876415 @default.
• W3156137002 date "2021-04-13" @default.
• W3156137002 modified "2023-09-27" @default.
• W3156137002 title "Abstract PO-017: Radiotherapy in combination with the brain penetrant ATM inhibitor AZD1390 does not exacerbate radiation toxicity of neural stem cells in vitro or in vivo" @default.
• W3156137002 doi "https://doi.org/10.1158/1557-3265.radsci21-po-017" @default.
• W3156137002 hasPublicationYear "2021" @default.
• W3156137002 type Work @default.
• W3156137002 sameAs 3156137002 @default.
• W3156137002 citedByCount "0" @default.
• W3156137002 crossrefType "proceedings-article" @default.
• W3156137002 hasAuthorship W3156137002A5001108212 @default.
• W3156137002 hasAuthorship W3156137002A5030868726 @default.
• W3156137002 hasAuthorship W3156137002A5032660674 @default.
• W3156137002 hasAuthorship W3156137002A5050483295 @default.
• W3156137002 hasAuthorship W3156137002A5055892643 @default.
• W3156137002 hasAuthorship W3156137002A5070984695 @default.
• W3156137002 hasAuthorship W3156137002A5084876415 @default.
• W3156137002 hasBestOaLocation W31561370022 @default.
• W3156137002 hasConcept C123012128 @default.
• W3156137002 hasConcept C136834591 @default.
• W3156137002 hasConcept C142724271 @default.
• W3156137002 hasConcept C143425029 @default.
• W3156137002 hasConcept C162746124 @default.
• W3156137002 hasConcept C190283241 @default.
• W3156137002 hasConcept C202751555 @default.
• W3156137002 hasConcept C207001950 @default.
• W3156137002 hasConcept C20875687 @default.
• W3156137002 hasConcept C28328180 @default.
• W3156137002 hasConcept C31573885 @default.
• W3156137002 hasConcept C502942594 @default.
• W3156137002 hasConcept C54355233 @default.
• W3156137002 hasConcept C552990157 @default.
• W3156137002 hasConcept C55493867 @default.
• W3156137002 hasConcept C71924100 @default.
• W3156137002 hasConcept C86803240 @default.
• W3156137002 hasConcept C95444343 @default.
• W3156137002 hasConceptScore W3156137002C123012128 @default.
• W3156137002 hasConceptScore W3156137002C136834591 @default.
• W3156137002 hasConceptScore W3156137002C142724271 @default.
• W3156137002 hasConceptScore W3156137002C143425029 @default.
• W3156137002 hasConceptScore W3156137002C162746124 @default.
• W3156137002 hasConceptScore W3156137002C190283241 @default.
• W3156137002 hasConceptScore W3156137002C202751555 @default.
• W3156137002 hasConceptScore W3156137002C207001950 @default.
• W3156137002 hasConceptScore W3156137002C20875687 @default.
• W3156137002 hasConceptScore W3156137002C28328180 @default.
• W3156137002 hasConceptScore W3156137002C31573885 @default.
• W3156137002 hasConceptScore W3156137002C502942594 @default.
• W3156137002 hasConceptScore W3156137002C54355233 @default.
• W3156137002 hasConceptScore W3156137002C552990157 @default.
• W3156137002 hasConceptScore W3156137002C55493867 @default.
• W3156137002 hasConceptScore W3156137002C71924100 @default.
• W3156137002 hasConceptScore W3156137002C86803240 @default.
• W3156137002 hasConceptScore W3156137002C95444343 @default.
• W3156137002 hasLocation W31561370021 @default.
• W3156137002 hasLocation W31561370022 @default.
• W3156137002 hasOpenAccess W3156137002 @default.
• W3156137002 hasPrimaryLocation W31561370021 @default.
• W3156137002 hasRelatedWork W1544124332 @default.
• W3156137002 hasRelatedWork W2048784291 @default.
• W3156137002 hasRelatedWork W2050306700 @default.
• W3156137002 hasRelatedWork W2328739198 @default.
• W3156137002 hasRelatedWork W2348627470 @default.
• W3156137002 hasRelatedWork W2365743016 @default.
• W3156137002 hasRelatedWork W2382491987 @default.
• W3156137002 hasRelatedWork W3032174019 @default.
• W3156137002 hasRelatedWork W4317209837 @default.
• W3156137002 hasRelatedWork W49676806 @default.
• W3156137002 isParatext "false" @default.
• W3156137002 isRetracted "false" @default.
• W3156137002 magId "3156137002" @default.
• W3156137002 workType "article" @default.